NCT07248436Completed
"Validity and Reliability of Pelvic Floor Distress Inventory-20 in Primary Sjögren's Syndrome"
"Investigation of the Validity and Reliability of the Pelvic Floor Distress Inventory-20 in Individuals With Primary Sjögren's Syndrome."
Source: ClinicalTrials.gov · Last updated 25 Nov 2025
Brief summary (registry, in English)
The aim of this study is to examine the Turkish validity and reliability of the Pelvic Floor Distress Inventory-20 in patients with pSS.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 10 (actual)
- First submitted
- 18 Nov 2025
- Start date
- 28 Mar 2025
- Primary completion date
- 28 May 2025
- Lead sponsor
- Pamukkale University
- Diseases
- Sjögren's disease
- NCT number
- NCT07248436
What you commit to
- Study type: Observational
- Participants enrolled: 10
- From 28 Mar 2025 to the primary completion date, 28 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of neurological disease
- History of orthopedic surgery
- Presence of psychiatric disorder that may affect cooperation
Other
- Presence of any orthopedic problem that may affect functionality
Who the study is looking for
- Being diagnosed with Primary Sjögren's Syndrome by the PAÜ Rheumatology clinic
- Being between the ages of 18 and 65
- Volunteering to participate in the study
Age in the registry: 18 years to 65 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pamukkale Üniversitesi Coordinator of this site? Confirm its status | Pamukkale | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.